0001493152-24-004815.txt : 20240202 0001493152-24-004815.hdr.sgml : 20240202 20240202200015 ACCESSION NUMBER: 0001493152-24-004815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240202 FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SNYDER DAVID S CENTRAL INDEX KEY: 0001398625 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41583 FILM NUMBER: 24593563 MAIL ADDRESS: STREET 1: ONE SCIENCE COURT CITY: MADISON STATE: WI ZIP: 53711 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coya Therapeutics, Inc. CENTRAL INDEX KEY: 0001835022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 BUSINESS PHONE: 650.739.3939 MAIL ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 4 1 ownership.xml X0508 4 2024-02-02 0 0001835022 Coya Therapeutics, Inc. COYA 0001398625 SNYDER DAVID S 5850 SAN FELIPE ST., SUITE 500 HOUSTON, TX 77057 0 1 0 0 Chief Financial Officer 0 Stock Option (right to buy) 5.90 2024-01-31 4 A 0 81819 0 A 2034-01-31 Common Stock 81819 81819 D The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date. /s/ David Snyder 2024-02-02